Frindovyx Injection
Product Images NDC 83831-121

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Frindovyx (NDC 83831-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8b6290e7 533f 4b49 8f00 A84e22abfb35 01)

Chemical structure of Cyclophosphamide, showing a phosphorus atom within a six-membered ring containing oxygen, with attached NH group, chlorine-substituted ethyl chains, and a water molecule (hydrate) indicated.*

FDA Label Image

Frindovyx (cyclophosphamide) Injection, 500mg/ml (Vial Label)

Label for Frindovyx (cyclophosphamide) Injection 500 mg/mL, an intravenous injection by Avyxa Pharma, LLC. The label includes a caution to dilute before intravenous use and notes it is a hazardous, multiple-dose vial requiring refrigeration at 2°C to 8°C (36°F to 46°F). It also provides manufacturing details and storage instructions.*

FDA Label Image

Frindovyx (cyclophosphamide) Injection, 500 mg/ mL (Carton Label)

Frindovyx 500 mg/mL (cyclophosphamide) Injection label, an intravenous multiple-dose vial by Avyxa Pharma, LLC. The label indicates it is a hazardous drug, must be diluted before intravenous use, sterile, and Rx only. Manufactured in India with storage instructions and caution for dilution using specific solutions. Includes Avyxa logo and barcode.*

FDA Label Image

Frindovyx (cyclophosphamide) Injection, 1 G/2 mL (Vial Label)

Frindovyx (cyclophosphamide) Injection label showing 1 gram/2 mL (500 mg/mL) strength. The label includes instructions to dilute before intravenous use, notes it is a multiple-dose vial and hazardous drug, and states it is for prescription use only. Manufactured for Avyxa Pharma, LLC.*

FDA Label Image

Frindovyx (cyclophosphamide) Injection, 1 G/2 mL (Carton Label)

The packaging label for Frindovyx (cyclophosphamide) Injection displays the 1 gram/2 mL (500 mg/mL) dosage form. It is a sterile, hazardous drug indicated for intravenous use, presented in a multiple-dose vial. The label shows that the product is manufactured for Avyxa Pharma, LLC and must be diluted before administration. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F). The label includes the Avyxa logo and notes the product is Rx only.*

FDA Label Image

Frindovyx (cyclophosphamide) Injection, 2 G/4 mL (Vial Label)

Frindovyx (cyclophosphamide) Injection 2 gram/4 mL (500 mg/mL) multiple-dose vial label. It includes cautions to dilute before intravenous use and store refrigerated at 2°C to 8°C. Manufactured for Avyxa Pharma, LLC, made in India, with storage and dosage information and barcode visible.*

FDA Label Image

Frindovyx (cyclophosphamide) Injection, 2 G/ 4 mL (Carton Label)

Frindovyx (cyclophosphamide) Injection 2 gram per 4 mL (500 mg/mL) multiple-dose vial label by Avyxa Pharma, LLC. The label states it is a hazardous drug for intravenous use that must be diluted before administration, sterile, and Rx only. It includes storage instructions to refrigerate between 2°C to 8°C (36°F to 46°F). Manufactured in India for Avyxa Pharma, LLC, New Jersey, USA.*

FDA Label Image

Image (8b6290e7 533f 4b49 8f00 A84e22abfb35 126 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.